Science Corporation announces $400M Series D; $3.5B valuation independently reported
Science Corporation announces $400M Series D; $3.5B valuation independently reported
Science Corporation confirmed $400M Series D on November 17; no issuer-confirmed lead investor or valuation. TechCrunch attributed an approximately $3.5B valuation to an unnamed person familiar with the deal, without independently established pre/post-money basis. EU PRIMA CE marking is not US FDA marketing approval.